Authors:
Slavin, S
Or, R
Aker, M
Shapira, MY
Panigrahi, S
Symeonidis, A
Cividalli, G
Nagler, A
Citation: S. Slavin et al., Nonmyeloablative stem cell transplantation for the treatment of cancer andlife-threatening nonmalignant disorders: past accomplishments and future goals, CANC CHEMOT, 48, 2001, pp. S79-S84
Authors:
Nagler, A
Aker, M
Or, R
Naparstek, E
Varadi, G
Brautbar, C
Slavin, S
Citation: A. Nagler et al., Low-intensity conditioning is sufficient to ensure engraftment in matched unrelated bone marrow transplantation, EXP HEMATOL, 29(3), 2001, pp. 362-370
Authors:
Kapelushnik, J
Shalev, C
Yaniv, I
Aker, M
Carmi, R
Cohen, Z
Mozer, A
Schulman, C
Stein, G
Or, R
Citation: J. Kapelushnik et al., Osteopetrosis: a single centre experience of stem cell transplantation andprenatal diagnosis, BONE MAR TR, 27(2), 2001, pp. 129-132
Citation: E. Granot et al., Monoclonal anti-CD52 antibodies: A potential mode of therapy for parvovirus B-19 hepatitis, TRANSPLAN P, 33(3), 2001, pp. 2151-2153
Authors:
Slavin, S
Or, R
Prighozina, T
Gurevitch, O
Aker, M
Panighari, S
Shapira, M
Nagler, A
Citation: S. Slavin et al., Immunotherapy of hematologic malignancies and metastatic solid tumors in experimental animals and man, BONE MAR TR, 25, 2000, pp. S54-S57
Citation: M. Aker et al., Fludarabine-based protocol for human umbilical cord blood transplantation in children with fanconi anemia, J PED H ONC, 21(3), 1999, pp. 237-239